Bullet Blog #1: Welcome Aboard the KEVLARx Bullet Train

May 6, 2024

The KEVLARx Bullet Train has finally left the station. Tickets please. Final destination: head-and-neck cancer with stops at several top-notch clinical trial sites and institutions along the way. These sites are the following, with more coming soon:

  • The Ohio State University, Columbus OH
    • Marcelo Bonomi
  • University of Michigan, Ann Arbor MI
    • Francis Worden
  • Renown Health, Reno NV
    • Abhinand Peddada
  • Northwestern, Chicago IL
    • Laila Gharzai
  • University of Texas (UT) Southwestern, Dallas TX
    • David Sher
  • Banner MD Anderson Cancer Center, Gilbert AZ
    • Gary Walker
  • University of North Carolina at Chapel Hill, Chapel Hill NC
    • Siddharth Sheth
  • East Carolina University, Greenville NC
    • Darla Liles
  • The University of Alabama at Birmingham, Birmingham AL
    • Sharon Spencer
  • The University of Arizona, Tucson AZ
    • Jared Robbins
  • Thomas Jefferson University, Philadelphia PA
    • Voichita Bar Ad
  • Baptist Health Miami Cancer Institute, Miami FL
    • Noah Kalman
  • Greater Baltimore Medical Center, Baltimore MD
    • Geoffrey Neuner
  • University of Virginia Health (UVA Health), Charlottesville VA
    • Varinder Kaur
  • Ballad Health, Johnson City TN
    • Kyle Colvett
  • Parkview Research Center, Fort Wayne IN
    • Brian Chang

Welcome aboard, everyone!